HAEM5:Splenic marginal zone lymphoma: Difference between revisions
| [unchecked revision] | [unchecked revision] |
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
{{Under Construction}} | {{Under Construction}} | ||
<blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023- | <blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023-12-04. The original page can be found at [[HAEM4:Splenic Marginal Zone Lymphoma]]. | ||
}}</blockquote> | }}</blockquote> | ||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
| Line 13: | Line 13: | ||
==Cancer Category / Type== | ==Cancer Category / Type== | ||
*[[Mature B-Cell Neoplasms]] | *[[HAEM4:Mature B-Cell Neoplasms]] | ||
==Cancer Sub-Classification / Subtype== | ==Cancer Sub-Classification / Subtype== | ||
| Line 168: | Line 168: | ||
|BRAF mutations | |BRAF mutations | ||
|Diagnostic (exclusion) | |Diagnostic (exclusion) | ||
|Present in [[Hairy | |Present in [[HAEM5:Hairy cell leukaemia|hairy cell leukemia (HCL)]] and absent in SMZL<ref>{{Cite journal|last=Naseem|first=Shano|last2=Gupta|first2=Ojas|last3=Binota|first3=Jogeshwar|last4=Varma|first4=Neelam|last5=Varma|first5=Subhash|last6=Malhotra|first6=Pankaj|date=2020|title=BRAF V600E mutation detection in hairy cell leukemia-utility of archival DNA from bone marrow aspirate/imprint smear and amplification refractory mutation system|url=http://link.springer.com/10.1007/s11033-020-05509-0|journal=Molecular Biology Reports|language=en|doi=10.1007/s11033-020-05509-0|issn=0301-4851}}</ref> | ||
|- | |- | ||
|MYD88 mutations | |MYD88 mutations | ||
|Diagnostic (exclusion) | |Diagnostic (exclusion) | ||
|Present in [[Lymphoplasmacytic | |Present in [[HAEM5:Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma (LPL)]] and rare but not absent in SMZL | ||
|- | |- | ||
|t(11;14)(q13;q32)/IGH-CCND1* | |t(11;14)(q13;q32)/IGH-CCND1* | ||
|Diagnostic (exclusion) | |Diagnostic (exclusion) | ||
|Present in [[Mantle | |Present in [[HAEM5:Mantle cell lymphoma|mantle cell lymphoma (MCL)]] and absent in SMZL | ||
|- | |- | ||
|t(14;18)(q32;q21)/IGH-BCL2 | |t(14;18)(q32;q21)/IGH-BCL2 | ||
|Diagnostic (exclusion) | |Diagnostic (exclusion) | ||
|Present in [[Follicular | |Present in [[HAEM5:Follicular lymphoma|follicular lymphoma (FL)]] and rare but not absent in SMZL<ref name=":1" /> | ||
|- | |- | ||
|t(11;18)(q21;q21)/BIRC3-MALT1 | |t(11;18)(q21;q21)/BIRC3-MALT1 | ||
|Diagnostic (exclusion) | |Diagnostic (exclusion) | ||
|Present in [[Extranodal | |Present in [[HAEM5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue|MALT lymphoma]] and absent in SMZL | ||
|- | |- | ||
|t(14;18)(q32;q21)/IGH-MALT1 | |t(14;18)(q32;q21)/IGH-MALT1 | ||
|Diagnostic (exclusion) | |Diagnostic (exclusion) | ||
|Present in [[Extranodal | |Present in [[HAEM5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue|MALT lymphoma]] and absent in SMZL<ref>{{Cite journal|last=Streubel|first=Berthold|last2=Lamprecht|first2=Andrea|last3=Dierlamm|first3=Judith|last4=Cerroni|first4=Lorenzo|last5=Stolte|first5=Manfred|last6=Ott|first6=German|last7=Raderer|first7=Markus|last8=Chott|first8=Andreas|date=2003|title=T(14;18)(q32;q21) involving IGH andMALT1 is a frequent chromosomal aberration in MALT lymphoma|url=https://ashpublications.org/blood/article/101/6/2335/106539/T1418q32q21-involving-IGH-andMALT1-is-a-frequent|journal=Blood|language=en|volume=101|issue=6|pages=2335–2339|doi=10.1182/blood-2002-09-2963|issn=1528-0020}}</ref> | ||
|- | |- | ||
|t(1;14)(p22;q32)/IGH-BCL10 | |t(1;14)(p22;q32)/IGH-BCL10 | ||
|Diagnostic (exclusion) | |Diagnostic (exclusion) | ||
|Present in [[Extranodal | |Present in [[HAEM5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue|MALT lymphoma]] and absent in SMZL | ||
|} | |} | ||
<nowiki>*</nowiki>Cases previously reported as SMZL with IGH-CCND1 fusion should now be classified as MCL | <nowiki>*</nowiki>Cases previously reported as SMZL with IGH-CCND1 fusion should now be classified as MCL | ||
| Line 465: | Line 465: | ||
==Links== | ==Links== | ||
*[[Splenic B-cell Lymphoma/Leukemia, Unclassifiable]] | *[[HAEM4:Splenic B-cell Lymphoma/Leukemia, Unclassifiable]] | ||
*[[Splenic | *[[HAEM5:Splenic diffuse red pulp small B-cell lymphoma]] | ||
==References== | ==References== | ||